Specifically, in colon cancer cells selected for resistance to methotrexate (HT29-5M21 or M12) or with higher metastatic potential (Lovo E2 versus LovoE5), caveolin-1 levels are elevated with respect to those detected in the wild-type cells [163]. This evidence concerns the gene CAV1 and colonic neoplasm.